Six papers
by Yu-Mei Tan
- D Hoer, HA Barton, A Paini, M Bartels, B Ingle, J Domoradzki, J Fisher, M Embry, P Villanueva, D Miller, J Nguyen, Q Zhang, SW Edwards, and YM Tan. Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling. Toxicol Appl Pharmacol 440 : 115922 (Feb 15, 2022). [abstract] [pubmed]
- RA Clewell, JA Leonard, CI Nicolas, JL Campbell, M Yoon, AY Efremenko, PD McMullen, ME Andersen, HJ Clewell, KA Phillips, and YM Tan. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates. Toxicol In Vitro 66 : 104855 (Aug 8, 2020). [abstract] [pubmed]
- YM Tan, M Chan, A Chukwudebe, J Domoradzki, J Fisher, CE Hack, P Hinderliter, K Hirasawa, J Leonard, A Lumen, A Paini, H Qian, P Ruiz, J Wambaugh, F Zhang, and M Embry. PBPK model reporting template for chemical risk assessment applications. Regul Toxicol Pharmacol 115 : 104691 (Aug 2, 2020). [abstract] [pubmed]
- JA Leonard, C Stevens, K Mansouri, D Chang, H Pudukodu, S Smith, and YM Tan. A Workflow for Identifying Metabolically Active Chemicals to Complement in vitro Toxicity Screening. Comput Toxicol 6 : 71-83 (May 1, 2018). [abstract] [pubmed]
- M Moreau, J Leonard, KA Phillips, J Campbell, SN Pendse, C Nicolas, M Phillips, M Yoon, YM Tan, S Smith, H Pudukodu, K Isaacs, and H Clewell. Using exposure prediction tools to link exposure and dosimetry for risk-based decisions: A case study with phthalates. Chemosphere 184 : 1194-1201 (Oct 24, 2017). [abstract] [pubmed]
- H El-Masri, N Kleinstreuer, RN Hines, L Adams, T Tal, K Isaacs, BA Wetmore, and YM Tan. Integration of Life-Stage Physiologically Based Pharmacokinetic Models with Adverse Outcome Pathways and Environmental Exposure Models to Screen for Environmental Hazards. Toxicol Sci 152 (1) : 230-43 (Jul 4, 2016). [abstract] [pubmed]